← Leaderboards
Jennifer F Friedman
Rhode Island Hospital
$14,043,058
Attributed
$16,887,553
Total exposure
17
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,377,826 · 18
By mechanism
U01$7,125,933 · 3
P20$3,764,610 · 3
R01$3,666,126 · 3
K24$1,739,571 · 1
P01$1,033,058 · 2
K23$623,724 · 1
Top collaborators
- Amaya Lopez Bustinduy6 shared
- Fusun Gundogan4 shared
- Mario Antonio Ii Larida Jiz3 shared
- Jonathan D. Kurtis1 shared
Others in their field
Top investigators on “Philippines”
- Jennifer E Lansford · Duke University$13,932,362
- Jeffrey C Murray · University Of Iowa$12,350,686
- Antonino None Catanzaro · University Of California San Diego$10,877,063
- Axel T Lehrer · Hawaii Biotech, Inc.$8,359,666
- Linda S Adair · Univ Of North Carolina Chapel Hill$8,347,731
- Kenneth H Mayer · Brigham And Women'S Hospital$7,705,833
Research focus
PhilippinesPraziquantelMorbidity - Disease RateSchistosomiasisInfectionMediatingResearch PersonnelSchistosoma JaponicumSerumPathogenesisAreaFetal Growth RetardationRandomized Controlled TrialsFundingSitePlacentaGrowthPregnancyInflammatoryInflammationPregnant WomenBaseChildBirth
Grant awards (64)
Translational Approaches for Pathogens of Human Significance$2,490,273
P20 · FY2025 · GM · contact PI
Administrative Core$667,580
P20 · FY2025 · GM · contact PI
An RCT to Evaluate Treatment Modalities to Halt the Progression of Schistosomiasis Related Hepatic Fibrosis$328,265
R01 · FY2025 · AI · contact PI
An RCT to Evaluate Treatment Modalities to Halt the Progression of Schistosomiasis Related Hepatic Fibrosis$249,762
R01 · FY2025 · AI · contact PI
Biomarkers to Identify Individuals at RIsk for Progression of S. Japonicum Associated Hepatic Fibrosis with Point of Care Test Development$601,595
U01 · FY2024 · AI · contact PI
Optimizing interventions to mitigate schistosomiasis-related morbidity among pregnant women and children$190,142
K24 · FY2024 · AI · contact PI
Biomarkers to Identify Individuals at RIsk for Progression of S. Japonicum Associated Hepatic Fibrosis with Point of Care Test Development$618,935
U01 · FY2023 · AI · contact PI
Optimizing interventions to mitigate schistosomiasis-related morbidity among pregnant women and children$190,493
K24 · FY2023 · AI · contact PI
Biomarkers to Identify Individuals at RIsk for Progression of S. Japonicum Associated Hepatic Fibrosis with Point of Care Test Development$632,001
U01 · FY2022 · AI · contact PI
Phase II PK/PD driven dose finding trial of Praziquantel in children under four$458,712
R01 · FY2022 · HD · contact PI
Optimizing interventions to mitigate schistosomiasis-related morbidity among pregnant women and children$190,834
K24 · FY2022 · AI · contact PI
Phase II PK/PD driven dose finding trial of Praziquantel in children under four$473,021
R01 · FY2021 · HD · contact PI
Optimizing interventions to mitigate schistosomiasis-related morbidity among pregnant women and children$191,165
K24 · FY2021 · AI · contact PI
Biostatistics and Data Management Core$125,431
P20 · FY2021 · GM · contact PI
Phase II PK/PD driven dose finding trial of Praziquantel in children under four$485,722
R01 · FY2020 · HD · contact PI
Undernutrition-helminth-alcohol interactions, placental mechanisms, and FASD risk$373,157
R01 · FY2020 · AA · contact PI
Optimizing interventions to mitigate schistosomiasis-related morbidity among pregnant women and children$191,487
K24 · FY2020 · AI · contact PI
Biostatistics and Data Management Core$146,718
P20 · FY2020 · GM · contact PI
Phase II PK/PD driven dose finding trial of Praziquantel in children under four$477,657
R01 · FY2019 · HD · contact PI
Undernutrition-helminth-alcohol interactions, placental mechanisms, and FASD risk$281,941
R01 · FY2019 · AA · contact PI
Microbial translocation, inflammation, and adverse pregnancy outcomes in humans$153,236
K24 · FY2019 · AI · contact PI
Biostatistics and Data Management Core$119,952
P20 · FY2019 · GM · contact PI
Phase II PK/PD driven dose finding trial of Praziquantel in children under four$537,889
R01 · FY2018 · HD · contact PI
Undernutrition-helminth-alcohol interactions, placental mechanisms, and FASD risk$270,592
U01 · FY2018 · AA · contact PI
Microbial translocation, inflammation, and adverse pregnancy outcomes in humans$154,246
K24 · FY2018 · AI · contact PI
Biostatistics and Data Management Core$119,961
P20 · FY2018 · GM · contact PI
Undernutrition-helminth-alcohol interactions, placental mechanisms, and FASD risk$272,381
U01 · FY2017 · AA · contact PI
Praziquantel for children under four: A Phase II PK/PD driven dose finding trial$205,387
R34 · FY2017 · AI · contact PI
Microbial translocation, inflammation, and adverse pregnancy outcomes in humans$158,290
K24 · FY2017 · AI · contact PI
Biostatistics and Data Management Core$94,695
P20 · FY2017 · GM · contact PI
Data Mangement and Statistics$58,493
P01 · FY2017 · AI · contact PI
Microbial translocation, inflammation, and adverse pregnancy outcomes in humans$160,391
K24 · FY2016 · AI · contact PI
Data Mangement and Statistics$59,137
P01 · FY2016 · AI · contact PI
S.japonicum, anemia, and iron transport in human pregnancy$198,750
R21 · FY2015 · AI · contact PI
Microbial translocation, inflammation, and adverse pregnancy outcomes in humans$159,287
K24 · FY2015 · AI · contact PI
Data Mangement and Statistics$52,613
P01 · FY2015 · AI · contact PI
S.japonicum, anemia, and iron transport in human pregnancy$238,500
R21 · FY2014 · AI · contact PI
Data Mangement and Statistics$58,495
P01 · FY2014 · AI · contact PI
Data Mangement and Statistics$62,144
P01 · FY2013 · AI · contact PI
S.japonicum and pregnancy outcomes: an RCT$283,120
U01 · FY2012 · AI · contact PI
S.japonicum and pregnancy outcomes: an RCT$299,104
U01 · FY2011 · AI · contact PI
Mechanisms mediating adverse birth outcomes in the context of S. Japonicum infect$106,668
K02 · FY2011 · AI · contact PI
S.japonicum and pregnancy outcomes: an RCT$900,505
U01 · FY2010 · AI · contact PI
Mechanisms mediating adverse birth outcomes in the context of S. Japonicum infect$105,921
K02 · FY2010 · AI · contact PI
S.japonicum and pregnancy outcomes: an RCT$916,703
U01 · FY2009 · AI · contact PI
Mechanisms mediating adverse birth outcomes in the context of S. Japonicum infect$105,195
K02 · FY2009 · AI · contact PI
Mechanisms mediating adverse birth outcomes in the context of S. Japonicum infect$49,152
K02 · FY2009 · AI · contact PI
S.japonicum and pregnancy outcomes: an RCT$941,861
U01 · FY2008 · AI · contact PI
Clinical and Research Resources Core$159,634
P50 · FY2008 · NS · contact PI
Mechanisms mediating adverse birth outcomes in the context of S. Japonicum infect$104,490
K02 · FY2008 · AI · contact PI
S.japonicum and pregnancy outcomes: an RCT$690,768
U01 · FY2007 · AI · contact PI
Clinical and Research Resources Core$191,626
P01 · FY2007 · NS · contact PI
S.japonicum and pregnancy outcomes: an RCT$698,368
U01 · FY2006 · AI · contact PI
Clinical and Research Resources Core$183,750
P01 · FY2006 · NS · contact PI
S. japonicum morbidity and pro-inflammatory cytokines$124,767
K23 · FY2006 · AI · contact PI
Inflammation, Iron, and Cognition in S. japonicum$74,706
R03 · FY2006 · AI · contact PI
Clinical and Research Resources Core$183,750
P01 · FY2005 · NS
S. japonicum morbidity and pro-inflammatory cytokines$100,543
K23 · FY2005 · AI
Inflammation, Iron, and Cognition in S. japonicum$76,401
R03 · FY2005 · AI
S. japonicum morbidity and pro-inflammatory cytokines$24,113
K23 · FY2005 · AI
Clinical and Research Resources Core$183,050
P01 · FY2004 · NS
S. japonicum morbidity and pro-inflammatory cytokines$124,767
K23 · FY2004 · AI
S. japonicum morbidity and pro-inflammatory cytokines$124,767
K23 · FY2003 · AI
S. japonicum morbidity and pro-inflammatory cytokines$124,767
K23 · FY2002 · AI